Almost all early stage medical device companies are extremely risky investments. The projected valuations of these stocks are hanging on to a thread, being solely based on the pending results and approval of potential life saving devices and procedures. These companies are not profitable and have accumulated a large deficit due to their focus on research and development. Neovasc Inc. (OTCPK:NVCIF) is no different. Buying stock in this company is extremely speculative and risky. Having said that, I believe Neovasc Inc offers one of the most compelling risk/reward profiles I have ever seen, and speculative investors should consider opening a position in this company immediately, here's why.
Neovasc is a Canadian medical device company that focuses on...
Only subscribers can access this article, which is part of the PRO research library covering 3,602 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: